1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. AMGEN INC.
AMGEN Inc. XNAS: AMGN

AMGEN Inc. Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first ...

Read More
298.43 6.43 (2.20%)
2.7M
XNAS Volume

XNAS 31 Oct, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for AMGEN Inc. is on 04 Nov 2025 for the purpose of Amgen Inc Third Quarter Earnings Result for 2025 See details
Durability score
High Financial Strength
61.1 / 100
Valuation Score
Mid Valuation
46.5 / 100
Momentum Score
Technically Neutral
49.4 / 100
Mid-range Performer These stocks are with strong quality. Their reasonable financials and technical aspects successfully gather investor's interest. View Similar Embed DVM
Analyst Price Target
312
1Yr Price target upside is 4%
26 analysts

9

S

7

W

1

O

3

T

SWOT Analysis

Amgen Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..